About
Contact & Profiles
A5002101350
Research Areas
- Blood Coagulation and Thrombosis Mechanisms
- Acute Ischemic Stroke Management
- Sepsis Diagnosis and Treatment
- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Neurological Complications and Syndromes
- Emergency and Acute Care Studies
- Heparin-Induced Thrombocytopenia and Thrombosis
- Case Reports on Hematomas
- Mechanical Circulatory Support Devices
Wesley Medical Center
2019-2021
Henry Ford Hospital
2020
10.1016/j.thromres.2020.02.021
article
EN
Thrombosis Research
2020-02-27
10.1016/j.ajem.2021.01.034
article
EN
The American Journal of Emergency Medicine
2021-01-18
The growing use of oral factor Xa (FXa) inhibitors in patients with chronic kidney disease (CKD), particularly the recent increased apixaban end-stage renal (ESRD), has created a new dilemma already controversial topic FXa inhibitor reversal. With limited availability anti-Xa levels specific to and even scarcer reversal data for on these agents ESRD, ensuring adequate is currently often solely guided by repeat imaging changes clinical status. Low molecular weight heparin (LMWH) have been...
10.1177/08971900211044288
article
EN
Journal of Pharmacy Practice
2021-09-25
Coming Soon ...